<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title></journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2013.1498</article-id>
<article-id pub-id-type="publisher-id">ol-06-04-1031</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Inhibition of autophagy by 3-MA enhances endoplasmic reticulum stress-induced apoptosis in human nasopharyngeal carcinoma cells</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>SONG</surname><given-names>LELE</given-names></name><xref rid="af1-ol-06-04-1031" ref-type="aff">1</xref><xref rid="af2-ol-06-04-1031" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>LIU</surname><given-names>HAO</given-names></name><xref rid="af1-ol-06-04-1031" ref-type="aff">1</xref><xref ref-type="corresp" rid="c1-ol-06-04-1031"/></contrib>
<contrib contrib-type="author">
<name><surname>MA</surname><given-names>LINYAN</given-names></name><xref rid="af1-ol-06-04-1031" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHANG</surname><given-names>XUDNG</given-names></name><xref rid="af2-ol-06-04-1031" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>JIANG</surname><given-names>ZHIWEN</given-names></name><xref rid="af1-ol-06-04-1031" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>JIANG</surname><given-names>CHENCHEN</given-names></name><xref rid="af3-ol-06-04-1031" ref-type="aff">3</xref><xref ref-type="corresp" rid="c1-ol-06-04-1031"/></contrib></contrib-group>
<aff id="af1-ol-06-04-1031">
<label>1</label>Faculty of Pharmacy, Bengbu Medical College, Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu, Anhui 233030, P.R. China</aff>
<aff id="af2-ol-06-04-1031">
<label>2</label>Department of Pharmacy, The First Affilated Hospital of Bengbu Medical College, Affilated Tumor Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China</aff>
<aff id="af3-ol-06-04-1031">
<label>3</label>Priority Research Center for Cancer Research, University of Newcastle, Callaghan, New South Wales 2308, Australia</aff>
<author-notes>
<corresp id="c1-ol-06-04-1031">Correspondence to: Professor Liu Hao, Faculty of Pharmacy, Bengbu Medical College, Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, 2600 Donghai Dadao, Bengbu, Anhui 233030, P.R. China, E-mail: <email>liuhao6886@yahoo.com.cn</email>. Professor Chenchen Jiang, Priority Research Center for Cancer Research, University of Newcastle, University Drive, Callaghan, New South Wales 2308, Australia, E-mail: <email>chenchen_jiang@yahoo.com.cn</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2013</year></pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>07</month>
<year>2013</year></pub-date>
<volume>6</volume>
<issue>4</issue>
<fpage>1031</fpage>
<lpage>1038</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>01</month>
<year>2013</year></date>
<date date-type="accepted">
<day>02</day>
<month>07</month>
<year>2013</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013, Spandidos Publications</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Radiotherapy and adjuvant cisplatin chemotherapy are the mainstream treatments for nasopharyngeal carcinoma (NPC), which effectively improve the outcome and reduce tumor recurrence. However, the resistance mechanism(s) involved in radiotherapy and chemotherapy, which is the main barrier in NPC treatment, remains undefined. Therefore, there is an urgent requirement for the identification of new therapeutic strategies or adjuvant drugs. In the present study, the effects of autophagy inhibitors on endoplasmic reticulum (ER) stress-induced autophagy was investigated. Combining 3-methyladenine (3-MA) with cisplatin (DDP), ionizing radiation (IR), 2-deoxy-D-glucose (2-DG) or tunicamycin (TM) resulted in enhanced cell death, as revealed by MTT and colony formation assays. Flow cytometry results demonstrated that the sensitivity of NPC cells to DDP- and IR-induced apoptosis was not significant. DDP, IR, 2-DG and TM induced ER stress and autophagy. Using fluorescence microscopy, 3-MA was identified to increase the apoptotic cell death induced by DDP, IR, 2-DG or TM. In addition, 3-MA inhibited the increased autophagy induced by DDP, IR, 2-DG or TM, as demonstrated by western blot analysis and immunocytochemistry results. Results of the present study indicate that autophagy acts as a protective mechanism response to the apoptosis induced by DDP, IR, 2-DG or TM.</p></abstract>
<kwd-group>
<kwd>nasopharyngeal carcinoma</kwd>
<kwd>autophagy</kwd>
<kwd>apoptosis</kwd>
<kwd>endoplasmic reticulum stress</kwd>
<kwd>ionizing radiation</kwd>
<kwd>3-methyladenine</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Inappropriate activation of survival signaling pathways causes uncontrolled proliferation, resistance to apoptosis and an increased motility of cells and is important for cancer development, progression and resistance to treatment (<xref rid="b1-ol-06-04-1031" ref-type="bibr">1</xref>). In nasopharyngeal carcinoma (NPC), standard treatments with systemic agents, including adjuvant cisplatin chemotherapy, has been unrewarding in general (<xref rid="b2-ol-06-04-1031" ref-type="bibr">2</xref>,<xref rid="b3-ol-06-04-1031" ref-type="bibr">3</xref>), which is primarily due to the failure in the induction of cell death and the development of the resistance mechanism(s) to chemotherapeutic reagents (<xref rid="b4-ol-06-04-1031" ref-type="bibr">4</xref>,<xref rid="b5-ol-06-04-1031" ref-type="bibr">5</xref>) and radioactive rays (<xref rid="b6-ol-06-04-1031" ref-type="bibr">6</xref>).</p>
<p>Apoptosis is the principal mechanism by which cells are physiologically eliminated in metazoan organisms (<xref rid="b7-ol-06-04-1031" ref-type="bibr">7</xref>). During apoptotic death, cells are digested by caspases and packaged into apoptotic bodies as a mechanism to avoid immune activation. Necrosis, previously hypothesized as a passive, unorganized method of cell death, has emerged as an alternate form of programmed cell death whose activation may have important biological consequences, including the induction of an inflammatory response (<xref rid="b7-ol-06-04-1031" ref-type="bibr">7</xref>). Autophagy has also been reported as a possible mechanism for non-apoptotic death despite evidence from a number of species showing that autophagy represents a survival strategy in times of stress. Recent advances have been important for the definition of the function and mechanism of programmed necrosis and the role of autophagy in cell survival and suicide (<xref rid="b7-ol-06-04-1031" ref-type="bibr">7</xref>).</p>
<p>Autophagy is a highly-conserved pathway in eukaryotic cells that has evolved to degrade bulk cytoplasmic material (<xref rid="b8-ol-06-04-1031" ref-type="bibr">8</xref>). Autophagy, a process of &#x02018;self-eating&#x02019;, has been classically studied in response to energy deprivation, including that which results from nutritional starvation of amino acids or fatty acids (<xref rid="b9-ol-06-04-1031" ref-type="bibr">9</xref>). Autophagy also provides an important function in the clearance of aggregated or misfolded proteins (<xref rid="b10-ol-06-04-1031" ref-type="bibr">10</xref>). However, it has also been reported to play a dual role in cancer and the induction of autophagy has been demonstrated to inhibit tumor cell growth and result in autophagic cell death (<xref rid="b11-ol-06-04-1031" ref-type="bibr">11</xref>). By contrast, it has been shown that autophagy may function as a cytoprotective mechanism by responding to stress situations, including hypoxia, low energy, oxidative stress and damaged mitochondria (<xref rid="b12-ol-06-04-1031" ref-type="bibr">12</xref>).</p>
<p>In the present study, we aimed to investigate the role of 3-methyladenine (3-MA) in NPC therapies, including chemotherapy and radiotherapy, as well as determine whether cisplatin (DDP), ionizing radiation (IR), 2-deoxy-D-glucose (2-DG) or tunicamycin (TM) induce autophagy via endoplasmic reticulum (ER) stress.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Cell lines</title>
<p>Human NPC cell lines, CNE-1 and CNE-2, were obtained from the American Type Culture Collection (Manassas, VA, USA) and maintained at the Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals (Anhui, China). Cells were cultured in DMEM medium containing 10&#x00025; NBCS (both Gibco-BRL, Carlsbad, CA, USA), 2 mmol/l L-glutamine, 100 U/ml penicillin and 100 &#x003BC;g/ml streptomycin and cultured at 37&#x000B0;C in a humidified atmosphere of 95&#x00025; air and 5&#x00025; CO<sub>2</sub>.</p></sec>
<sec>
<title>Drugs and antibodies</title>
<p>DDP was purchased from Qilu Pharmaceutical Co., Ltd. (Jinan, China). 2-DG and TM were purchased from Sigma-Aldrich (St. Louis, MO, USA). 3-MA was purchased from an affiliate of Merck KgaA (Darmstadt, Germany). Horseradish peroxidase (HRP)-conjugated anti-rabbit IgG, anti-rabbit IgG (H&#x0002B;L chains)-fluorescein isothiocyanate (FITC), anti-LC3 and anti-beclin 1 were purchased from MBL Biotech Co. (Beijing, China). &#x003B2;-actin was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).</p></sec>
<sec>
<title>Cell proliferation assay</title>
<p>3-(4,5-Dimethylthiazol-2-yl)-2,5-di- phenyltetrazolium bromide (MTT)was performed as described previously (<xref rid="b13-ol-06-04-1031" ref-type="bibr">13</xref>). Briefly, cells were plated in 96-well culture clusters (Costar, Cambridge, MA, USA) at a density of 1&#x000D7;10<sup>5</sup> cells/well in triplicate. MTT (5.0 mg/l; 15 &#x003BC;l) was added 4 h later, followed by the addition of 150 &#x003BC;l DMSO into each well. The absorbance (A) of the formazan product was determined at 570 nm using a plate microreader and calculated using the following formula: Cell viability (&#x00025;) &#x0003D; (A<sub>sample</sub> &#x02212; A<sub>blank</sub>)/(A<sub>control</sub> &#x02212; A<sub>blank</sub>) &#x000D7; 100.</p></sec>
<sec>
<title>Annexin V/propidium iodide (PI)-FITC double staining</title>
<p>Cell apoptosis was detected using the annexin V-FITC apoptosis detection kit (BD Pharmingen, San Diago, CA, USA) according to the manufacturer&#x02019;s instructions. Briefly, the cells were seeded in 24-well plates and then subjected to various experimental conditions for 24 h. Following incubation, the cells were trypsinized and suspended in 1 ml phosphate buffered saline (PBS). In each cell suspension, 2&#x000D7;10<sup>5</sup> cells were centrifuged and re-suspended in 500 &#x003BC;l 1X binding buffer. In each sample, 5 &#x003BC;l annexin V-FITC and 5 &#x003BC;l PI were added. The mixture was incubated for 5 min in the dark and immediately analyzed using a FACSCalibur flow cytometer and Cell Quest software (BD Biosciences, San Jose, CA, USA).</p></sec>
<sec>
<title>Colony formation assay</title>
<p>A colony formation assay was performed as described previously (<xref rid="b14-ol-06-04-1031" ref-type="bibr">14</xref>). In brief, the cells were seeded at 1&#x000D7;10<sup>3</sup> cells/well in 6-well culture plates, allowed to grow for 24 h and then treated as indicated. The cells were then washed twice with ice-cold PBS and fixed with ice-cold methanol for 10 min. Methanol was aspirated off from the plates, 0.5&#x00025; crystal violet solution (Sciencelab.com, Inc., Houston, TX, USA) was added and the plates were incubated at room temperature for 10 min. Distilled water was used to rinse the plate. Images were captured with the Bio-Rad VersaDoc&#x02122; imaging system (Hercules, CA, USA).</p></sec>
<sec>
<title>Western blot analysis</title>
<p>A western blot analysis was performed as described previously (<xref rid="b15-ol-06-04-1031" ref-type="bibr">15</xref>). Labeled bands were detected by the Immun-Star&#x02122; HRP Chemiluminescence kit (Bio-Rad) and images were captured using the Bio-Rad VersaDoc image system.</p></sec>
<sec>
<title>Immunocytochemistry</title>
<p>The cells were seeded in 12-well plates at a density of 1.2&#x000D7;10<sup>5</sup> cells/well. Following 24 h of drug or IR exposure, the cells were washed with PBS twice and fixed with PBS containing 4&#x00025; paraformaldehyde for 15 min at room temperature. Subsequent to being blocked with 5&#x00025; bovine serum albumin for 2 h, the cells were washed with PBS and incubated with anti-beclin 1 antibody (1:100) overnight at 4&#x000B0;C. The cells were then washed with PBS and incubated in the dark with 100 &#x003BC;l FITC-conjugated anti-rabbit IgG (1:100) for 2 h. The cells were washed with PBS and the fluorescence signal was detected by an inverted fluorescent microscope (Olympus Corporation, Tokyo, Japan).</p></sec>
<sec>
<title>DAPI staining</title>
<p>The cells were seeded in 12-well plates at a density of 1.2&#x000D7;10<sup>5</sup> cells/well. Following 24 h of drug or IR exposure, the cells were washed with PBS twice and fixed with PBS containing 4&#x00025; PFA for 15 min at room temperature. The cells were washed further with PBS and then stained with 10 &#x003BC;g/ml DAPI (Beyotime Biotech, Jiangsu, China) for 5 min in the dark at room temperature. The solution was then removed and the cells were washed twice with PBS and analyzed using an inverted fluorescence microscope.</p></sec>
<sec>
<title>Mitochondrial membrane potential (&#x00394;&#x003C8;m)</title>
<p>The cells were seeded at 1&#x000D7;10<sup>5</sup> cells/well in 24-well plates and allowed to culture to reach exponential growth for 24 h prior to treatment. Changes in &#x00394;&#x003C8;m were studied by staining the cells with the cationic dye, JC-1, according to the manufacturer&#x02019;s instructions (Molecular Probes, Eugene, OR, USA), as described previously (<xref rid="b16-ol-06-04-1031" ref-type="bibr">16</xref>). CCCP, which induces apoptosis, was used as the positive control.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>All experiments described were performed at least in triplicate. Data are expressed as mean &#x000B1; SD. All statistical analyses were performed using two-tailed paired Student&#x02019;s t-tests. P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Sensitivity of human NPC cells to DDP- and IR-induced apoptosis is not significant</title>
<p>The proliferation of the NPC cells was inhibited by various concentrations of DDP and IR (<xref rid="f1-ol-06-04-1031" ref-type="fig">Fig. 1A</xref>). This inhibition was enhanced with increasing concentrations of DDP and IR and prolonged with increasing duration of exposure of the cells to DDP and IR. Following treatment with 6.00 &#x003BC;mol/l DDP for 24, 36 and 48 h, the survival rate of the CNE-1 and CNE-2 cells reached 80.74, 79.95 and 78.92&#x00025; and 82.15, 82.05 and 79.13&#x00025;, respectively. Treatment of the CNE-1 and CNE-2 cells with 4 Gy IR for 24, 36 and 48 h resulted in a survival rate of 2.29, 73.51 and 62.35&#x00025; and 92.35, 83.58 and 72.37&#x00025;, respectively. Based on these results, 6.00 &#x003BC;mol/l DDP and 4 Gy IR was used, each for 24 h, for further experiments.</p>
<p>Following treatment with 6.00 &#x003BC;mol/l DDP for 24 h, the induction of apoptosis in the CNE-1 and CNE-2 cells was only 5.8 and 6.7&#x00025;, respectively, which was not statistically significant when compared with the negative control group (<xref rid="f1-ol-06-04-1031" ref-type="fig">Fig. 1B</xref>). Subsequent to treatment with 4 Gy IR for 24 h, the induction of apoptosis in the CNE-1 and CNE-2 cells was only 5.1 and 5.4&#x00025;, respectively, which was not statistically significant when compared with the negative control group (<xref rid="f1-ol-06-04-1031" ref-type="fig">Fig. 1B</xref>).</p></sec>
<sec>
<title>DDP and IR induce ER stress and autophagy in human NPC cells</title>
<p>It has been previously demonstrated that DDP and IR activate autophagy via ER stress (<xref rid="b17-ol-06-04-1031" ref-type="bibr">17</xref>). Therefore, the expression levels of GRP78, LC-3 and beclin 1 were determined. The levels of GRP78 and beclin 1 were increased in the cells treated with 6.00 &#x003BC;mol/l DDP or 4 Gy IR at various times (<xref rid="f1-ol-06-04-1031" ref-type="fig">Fig. 1C</xref>). Western blot analysis revealed that microtubule-associated protein 1 light chain 3 (LC3) was converted from the free form (LC3-I) to a lipid-conjugated membrane-bound form (LC3-II) in the cells treated with 6.00 &#x003BC;mol/l DDP or 4 Gy IR for 24 h (<xref rid="f1-ol-06-04-1031" ref-type="fig">Fig. 1C</xref>). As hypothesized, these observations indicate that DDP or IR induces ER stress and autophagy in human NPC cells.</p></sec>
<sec>
<title>3-MA enhances the sensitivity of human NPC cells to DDP and IR</title>
<p>The proliferation of the NPC cells was inhibited by various concentrations of 3-MA (P&lt;0.05; <xref rid="f1-ol-06-04-1031" ref-type="fig">Fig. 1D</xref>). Inhibition was enhanced with increasing concentrations of 3-MA and prolonged with increasing duration of cell exposure to 3-MA. Combining 1 mmol/l 3-MA with 6.00 &#x003BC;mol/l DDP or 4 Gy IR reduced cell viability compared with the individual use of each agent, as revealed by MTT assay (<xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2A</xref>). Colony formation assays were used to further confirm that 3-MA enhanced the sensitivity of the NPC cells to DDP or IR. The two cell lines formed fewer colonies when treated with 3-MA (0.1 mmol/l) in the presence of DDP (0.60 &#x003BC;mol/l) or IR (0.4 Gy) compared with the individual agent (<xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2B</xref>).</p>
<p>JC-1 staining assay results reveal the conversion of fluorescence from red to green in the cells treated with 50 &#x003BC;mol/l CCCP for 20 min. Following treatment with 1 mmol/l 3-MA combined with 6.00 &#x003BC;mol/l DDP or 4 Gy IR for 24 h, the extent of the conversion of fluorescence from red to green in the cells was significant (<xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2C</xref>). These observations indicate that 3-MA promotes apoptosis in DDP- or IR-treated NPC cells. Consistent with this, the DAPI staining results in <xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2D</xref> revealed typical morphological changes, including chromatin condensation and apoptotic body formation, in the NPC cells treated with 3-MA combined with DDP or IR. By contrast, the cells in the control group did not reveal any abnormal morphologies. These results indicate that 3-MA promotes apoptosis in IR- or DDP-treated NPC cells.</p></sec>
<sec>
<title>Effects of 3-MA with DDP or IR on autophagy in human NPC cells</title>
<p>The GRP78 and beclin 1 protein levels were increased in the cells treated with 6.00 &#x003BC;mol/l DDP or 4 Gy IR for 24 h. Western blot analysis revealed the conversion of LC3 from LC3-I to LC3-II in the cells treated with 6.00 &#x003BC;mol/l DDP or 4 Gy IR for 24 h (<xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2E</xref>). Notably, the treatment with 1 mmol/l 3-MA reversed these effects. The results from the immunocytochemistry analysis of the expression of beclin 1 further confirm these observations (<xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2F</xref>).</p></sec>
<sec>
<title>Effects of 3-MA with 2-DG or TM on the proliferation and apoptosis of human NPC cells</title>
<p>The proliferation of the NPC cells was inhibited by various concentrations of 2-DG or TM (<xref rid="f3-ol-06-04-1031" ref-type="fig">Fig. 3A</xref>). This inhibition was enhanced with increasing concentrations of 2-DG or TM, and prolonged with the increasing duration of cell exposure to 2-DG or TM. Following treatment with 5 mmol/l 2-DG for 24, 36 and 48 h, the survival rate of the CNE-1 and CNE-2 cells reached 72.13, 53.14 and 47.99&#x00025; and 69.32, 68.02 and 67.02&#x00025;, respectively. When the cells were treated with 2 &#x003BC;mol/l TM for 24, 48 and 72 h, the survival rate of the CNE-1 and CNE-2 cells reached 72.43, 69.05 and 65.13&#x00025; and 93.28, 91.58 and 79.21&#x00025;, respectively. Based on these results, 5 mmol/l 2-DG and 1 &#x003BC;mol/l TM were each used for 24 h for further experiments.</p>
<p>The treatment of the cells with 1 mmol/l 3-MA combined with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM reduced the cell viability compared with the individual use of each agent, as revealed by MTT assay (P&lt;0.05; <xref rid="f3-ol-06-04-1031" ref-type="fig">Fig. 3B</xref>). These results were further supported by the colony formation assays (<xref rid="f3-ol-06-04-1031" ref-type="fig">Fig. 3C</xref>).</p>
<p>Colony formation assays were used to further confirm the fact that 3-MA enhances the sensitivity of human NPC cells to 2-DG and TM. The two cell lines formed fewer colonies when treated with 3-MA in the presence of 2-DG or TM compared with with 2-DG or TM alone.</p>
<p>The treatment of the cells with 1 mmol/l 3-MA combined with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM for 24 h resulted in the significant conversion of fluorescence from red to green in the cells (<xref rid="f3-ol-06-04-1031" ref-type="fig">Fig. 3D</xref>). This indicates that 3-MA promotes apoptosis in 2-DG- or TM-treated NPC cells. These data were further supported by the DAPI staining results. <xref rid="f4-ol-06-04-1031" ref-type="fig">Fig. 4A</xref> demonstrates that the treatment of the cells with 2-DG or TM did not appreciably induce apoptosis in the cells, but typical morphological changes associated with apoptosis, including chromatin condensation, apoptotic body formation and DNA fragmentation, were evident in the cells treated with 3-MA combined with 2-DG or TM. By contrast, the cells in the control group did not exhibit any abnormal morphology.</p>
<p>The beclin 1 protein levels were increased in the cells treated with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM for 24 h (<xref rid="f4-ol-06-04-1031" ref-type="fig">Fig. 4B</xref>). Western blot analysis revealed the conversion of LC3 from LC3-I to LC3-II in the cells treated with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM for 24 h. Notably, 1 mmol/l 3-MA was able to reverse this effect. The results from the immunocytochemistry analysis of the expression of beclin 1 further confirmed these observations (<xref rid="f4-ol-06-04-1031" ref-type="fig">Fig. 4C</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The 5-year survival rate following the combination of radiotherapy and adjuvant DDP chemotherapy is only 50&#x02013;60&#x00025; and the rates of 5-year cumulative local relapse and distant metastasis are 20&#x02013;30 and 20&#x02013;25&#x00025;, respectively (<xref rid="b17-ol-06-04-1031" ref-type="bibr">17</xref>). Etiological factors that have been identified for NPC include Epstein-Barr virus infection, environmental risk factors and genetic susceptibility (<xref rid="b18-ol-06-04-1031" ref-type="bibr">18</xref>).</p>
<p>In the present study, DDP or IR was shown to induce cell death. However, the sensitivity of human NPC cells to DDP and IR-induced apoptosis was not significant.</p>
<p>Several studies have reported that ER stress induces autophagy in mammalian cancer cell lines and mouse embryonic fibroblasts (<xref rid="b19-ol-06-04-1031" ref-type="bibr">19</xref>,<xref rid="b20-ol-06-04-1031" ref-type="bibr">20</xref>). ER stress is caused by the accumulation of misfolded or premature proteins in the ER lumen or the cytosol. Changes in the environment of the ER lumen, including changes in calcium levels, redox status and ER function, all affect correct protein folding. The major mitigating mechanism for ER stress is the unfolded protein response (UPR), which is mediated by several signaling mechanisms that alleviate ER stress. In mammalian cells, UPR is mediated by the PERK, ATF6 and IRE1 pathways. Current studies support the hypothesis that an ER chaperone protein, BiP (also known as GRP78), serves as a master UPR regulator and plays essential roles in activating IRE1, PERK and ATF6 in response to ER stress (<xref rid="b7-ol-06-04-1031" ref-type="bibr">7</xref>,<xref rid="b13-ol-06-04-1031" ref-type="bibr">13</xref>). As demonstrated in yeast and mammalian cells (<xref rid="b9-ol-06-04-1031" ref-type="bibr">9</xref>,<xref rid="b11-ol-06-04-1031" ref-type="bibr">11</xref>), ER stress activates other major cellular degradation mechanisms, including autophagy, which, in turn, affects ER stress and, consequently, cell death.</p>
<p>3-MA is a popular inhibitor of the autophagic pathway (<xref rid="b20-ol-06-04-1031" ref-type="bibr">20</xref>). 3-MA has been reported to inhibit the activity of PI3-kinase and to block the formation of preautophagosomes, autophagosomes and autophagic vacuoles. Autophagy has been reported to increase as a result of chemotherapy, resulting in the autophagic cell death of cancer cells (programmed cell death) or the adaptation of cancer cells to cytotoxicity induced by drugs, including in apoptosis (<xref rid="b20-ol-06-04-1031" ref-type="bibr">20</xref>). However, although autophagy has been hypothesized to represent a potential therapeutic target in adjuvant chemotherapy, the exact role and relevance of autophagy, autophagic cell death and apoptosis in cancer remains poorly understood and appears to be more complex than previously considered.</p>
<p>In the present study, 3-MA in combination with DDP or IR was shown to increase cell death more markedly than using DDP or IR alone. As demonstrated in <xref rid="f2-ol-06-04-1031" ref-type="fig">Fig. 2C</xref>, 3-MA promoted apoptosis in the DDP- or IR-treated NPC cells. These data were further supported by the results of DAPI staining. Taken together, these results show that 3-MA enhances the sensitivity of NPC cells to DDP or IR. The western blot analysis revealed an increase in the GRP78 and beclin 1 protein levels, and the conversion of LC3 from LC3-I to LC3-II in the cells treated with DDP or IR. Notably, 3-MA was able to reverse this effect. These data were further supported by the immunocytochemistry analysis of beclin 1 expression. These observations indicate the important role of autophagy in ER stress-induced apoptosis.</p>
<p>In the current study, other ER stress inducers were used to demonstrate the broad applicability of our observations. The cells were exposed to the classic ER stress inducers, 2-DG and TM. 2-DG, a synthetic glucose analog that acts as a glycolytic inhibitor, is currently under clinical evaluation for targeting tumor cells. The glucosamine-containing nucleoside antibiotic, TM, is an inhibitor of N-linked glycosylation and of the formation of N-glycosidic protein-carbohydrate linkages.</p>
<p>The results from the MTT and colony formation assays demonstrated that the proliferation of the cells was inhibited by 2-DG and TM. 3-MA combined with 2-DG or TM reduced the cell viability compared with the individual use of each agent. These data were further supported by the results from the colony formation assay. The JC-1 staining assay revealed that 3-MA promotes apoptosis in the 2-DG- or TM-induced NPC cells. These data were further supported by the DAPI staining results.</p>
<p>Next, the molecular changes that occur following 2-DG or TM treatment were explored by immunoblotting assay. The beclin 1 protein levels increased following treatment with 2-DG or TM. Western blot analysis revealed the conversion of LC3 from LC3-I to LC3-II following treatment with 2-DG or TM. Notably, treatment with 3-MA reversed these effects. Finally, results from the immunocytochemistry analysis of the expression of beclin 1 further confirm these observations</p>
<p>The results of the present study indicate that autophagy is a protective mechanism in response to the apoptosis induced by DDP, IR, 2-DG or TM. These observations are likely to serve as a foundation for further investigations into autophagy in NPC. The extension of this study into <italic>in vivo</italic> studies and clinical trials is important.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by the National Natural Science Foundation of China (grant nos. 81000992 and 81072207), the Key Program of the Natural Science Foundation of Anhui province, China (grant no. KJ2012A202) and the Natural Science Foundation of Anhui Province, China (grant no. 090413135).</p></ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="G1">NPC</term>
<def>
<p>nasopharyngeal carcinoma</p></def></def-item>
<def-item>
<term id="G2">DDP</term>
<def>
<p>cisplatin</p></def></def-item>
<def-item>
<term id="G3">IR</term>
<def>
<p>ionizing radiation</p></def></def-item>
<def-item>
<term id="G4">2-DG</term>
<def>
<p>2-deoxy-D-glucose</p></def></def-item>
<def-item>
<term id="G5">TM</term>
<def>
<p>tunicamycin</p></def></def-item>
<def-item>
<term id="G6">3-MA</term>
<def>
<p>3-methyladenine</p></def></def-item>
<def-item>
<term id="G7">ER</term>
<def>
<p>endoplasmic reticulum</p></def></def-item>
<def-item>
<term id="G8">GRP78</term>
<def>
<p>glucose-regulated protein 78</p></def></def-item>
<def-item>
<term id="G9">UPR</term>
<def>
<p>unfolded protein response</p></def></def-item>
<def-item>
<term id="G10">PERK</term>
<def>
<p>protein kinase-like ER kinase</p></def></def-item>
<def-item>
<term id="G11">ATF6</term>
<def>
<p>activation of transcription factor 6</p></def></def-item>
<def-item>
<term id="G12">IRE1</term>
<def>
<p>inositol-requiring transmembrane kinase and endonuclease 1</p></def></def-item></def-list></glossary>
<ref-list>
<title>References</title>
<ref id="b1-ol-06-04-1031"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>MJ</given-names></name></person-group><article-title>Nasopharyngeal carcinoma as a paradigm of cancer genetics</article-title><source>Chin J Cancer</source><volume>30</volume><fpage>79</fpage><lpage>84</lpage><year>2011</year></element-citation></ref>
<ref id="b2-ol-06-04-1031"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Garden</surname><given-names>AS</given-names></name><name><surname>Straube</surname><given-names>W</given-names></name><name><surname>Glisson</surname><given-names>B</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Bosch</surname><given-names>W</given-names></name><name><surname>Morrison</surname><given-names>WH</given-names></name><name><surname>Quivey</surname><given-names>J</given-names></name><name><surname>Thorstad</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Ang</surname><given-names>KK</given-names></name></person-group><article-title>Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225</article-title><source>J Clin Oncol</source><volume>27</volume><fpage>3684</fpage><lpage>3690</lpage><year>2009</year></element-citation></ref>
<ref id="b3-ol-06-04-1031"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>KA</given-names></name><name><surname>Ang</surname><given-names>KK</given-names></name><name><surname>El-Naggar</surname><given-names>AK</given-names></name><name><surname>Story</surname><given-names>MD</given-names></name><name><surname>Lee</surname><given-names>JI</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Hong</surname><given-names>WK</given-names></name><name><surname>Mao</surname><given-names>L</given-names></name></person-group><article-title>Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma</article-title><source>Cancer Res</source><volume>62</volume><fpage>6414</fpage><lpage>6417</lpage><year>2002</year></element-citation></ref>
<ref id="b4-ol-06-04-1031"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Kudo</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>SY</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Kumara</surname><given-names>WR</given-names></name><name><surname>Tamura</surname><given-names>Y</given-names></name><name><surname>Ohta</surname><given-names>H</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Takiguchi</surname><given-names>M</given-names></name></person-group><article-title>Activation of microbubbles by short-pulsed ultrasound enhances the cytotoxic effect of cis-diamminedichloroplatinum (II) in a canine thyroid adenocarcinoma cell line in vitro</article-title><source>Ultrasound Med Biol</source><volume>38</volume><fpage>109</fpage><lpage>118</lpage><year>2011</year></element-citation></ref>
<ref id="b5-ol-06-04-1031"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberoi</surname><given-names>HS</given-names></name><name><surname>Laquer</surname><given-names>FC</given-names></name><name><surname>Marky</surname><given-names>LA</given-names></name><name><surname>Kabanov</surname><given-names>AV</given-names></name><name><surname>Bronich</surname><given-names>TK</given-names></name></person-group><article-title>Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II)</article-title><source>J Control Release</source><volume>153</volume><fpage>64</fpage><lpage>72</lpage><year>2011</year></element-citation></ref>
<ref id="b6-ol-06-04-1031"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastav</surname><given-names>M</given-names></name><name><surname>De Haro</surname><given-names>LP</given-names></name><name><surname>Nickoloff</surname><given-names>JA</given-names></name></person-group><article-title>Regulation of DNA double-strand break repair pathway choice</article-title><source>Cell Res</source><volume>18</volume><fpage>134</fpage><lpage>147</lpage><year>2008</year></element-citation></ref>
<ref id="b7-ol-06-04-1031"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witko-Sarsat</surname><given-names>V</given-names></name></person-group><article-title>Apoptosis, cell death and inflammation</article-title><source>J Innate Immun</source><volume>2</volume><fpage>201</fpage><lpage>203</lpage><year>2010</year></element-citation></ref>
<ref id="b8-ol-06-04-1031"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhogal</surname><given-names>RH</given-names></name><name><surname>Weston</surname><given-names>CJ</given-names></name><name><surname>Curbishley</surname><given-names>SM</given-names></name><name><surname>Adams</surname><given-names>DH</given-names></name><name><surname>Afford</surname><given-names>SC</given-names></name></person-group><article-title>Autophagy: A cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress</article-title><source>Autophagy</source><volume>8</volume><fpage>545</fpage><lpage>558</lpage><year>2012</year></element-citation></ref>
<ref id="b9-ol-06-04-1031"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name></person-group><article-title>Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury</article-title><source>Autophagy</source><volume>8</volume><fpage>577</fpage><lpage>592</lpage><year>2012</year></element-citation></ref>
<ref id="b10-ol-06-04-1031"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graziotto</surname><given-names>JJ</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Krainc</surname><given-names>D</given-names></name></person-group><article-title>Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome: implications for normal aging and age-dependent neurodegenerative disorders</article-title><source>Autophagy</source><volume>8</volume><fpage>147</fpage><lpage>151</lpage><year>2012</year></element-citation></ref>
<ref id="b11-ol-06-04-1031"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname><given-names>YX</given-names></name><name><surname>Fan</surname><given-names>XN</given-names></name><name><surname>Wang</surname><given-names>HM</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>SD</given-names></name></person-group><article-title>Glyphosate induced cell death through apoptotic and autophagic mechanisms</article-title><source>Neurotoxicol Teratol</source><volume>34</volume><fpage>344</fpage><lpage>349</lpage><year>2012</year></element-citation></ref>
<ref id="b12-ol-06-04-1031"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovaleva</surname><given-names>V</given-names></name><name><surname>Mora</surname><given-names>R</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Plass</surname><given-names>C</given-names></name><name><surname>Chiramel</surname><given-names>AI</given-names></name><name><surname>Bartenschlager</surname><given-names>R</given-names></name><name><surname>Dohner</surname><given-names>H</given-names></name><name><surname>Stilgenbauer</surname><given-names>S</given-names></name><name><surname>Pscherer</surname><given-names>A</given-names></name><name><surname>Lichter</surname><given-names>P</given-names></name><name><surname>Seiffert</surname><given-names>M</given-names></name></person-group><article-title>miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells</article-title><source>Cancer Res</source><volume>72</volume><fpage>1763</fpage><lpage>1772</lpage><year>2012</year></element-citation></ref>
<ref id="b13-ol-06-04-1031"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>ZY</given-names></name><name><surname>Zhu</surname><given-names>XF</given-names></name><name><surname>Zhong</surname><given-names>ZD</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Zeng</surname><given-names>YX</given-names></name></person-group><article-title>ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts</article-title><source>Int J Cancer</source><volume>123</volume><fpage>2418</fpage><lpage>2429</lpage><year>2008</year></element-citation></ref>
<ref id="b14-ol-06-04-1031"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Growth inhibition and apoptotic effect of alpha-eleostearic acid on human breast cancer cells</article-title><source>J Nat Med</source><volume>66</volume><fpage>77</fpage><lpage>84</lpage><year>2011</year></element-citation></ref>
<ref id="b15-ol-06-04-1031"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LH</given-names></name><name><surname>Jiang</surname><given-names>CC</given-names></name><name><surname>Kiejda</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>WF</given-names></name><name><surname>Thorne</surname><given-names>RF</given-names></name><name><surname>Zhang</surname><given-names>XD</given-names></name><name><surname>Hersey</surname><given-names>P</given-names></name></person-group><article-title>Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response</article-title><source>Carcinogenesis</source><volume>28</volume><fpage>2328</fpage><lpage>2336</lpage><year>2007</year></element-citation></ref>
<ref id="b16-ol-06-04-1031"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XD</given-names></name><name><surname>Wu</surname><given-names>JJ</given-names></name><name><surname>Gillespie</surname><given-names>S</given-names></name><name><surname>Borrow</surname><given-names>J</given-names></name><name><surname>Hersey</surname><given-names>P</given-names></name></person-group><article-title>Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin</article-title><source>Clin Cancer Res</source><volume>12</volume><fpage>1355</fpage><lpage>1364</lpage><year>2006</year></element-citation></ref>
<ref id="b17-ol-06-04-1031"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddique</surname><given-names>MA</given-names></name><name><surname>Sabur</surname><given-names>MA</given-names></name><name><surname>Kundu</surname><given-names>SC</given-names></name><name><surname>Mostafa</surname><given-names>MG</given-names></name><name><surname>Khan</surname><given-names>JA</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Karim</surname><given-names>MA</given-names></name><name><surname>Hanif</surname><given-names>MA</given-names></name></person-group><article-title>Difficulty in diagnosis of nasopharyngeal carcinoma</article-title><source>Mymensingh Med J</source><volume>21</volume><fpage>158</fpage><lpage>161</lpage><year>2012</year></element-citation></ref>
<ref id="b18-ol-06-04-1031"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carle</surname><given-names>LN</given-names></name><name><surname>Ko</surname><given-names>CC</given-names></name><name><surname>Castle</surname><given-names>JT</given-names></name></person-group><article-title>Nasopharyngeal carcinoma</article-title><source>Head Neck Pathol</source><volume>6</volume><fpage>364</fpage><lpage>368</lpage><year>2012</year></element-citation></ref>
<ref id="b19-ol-06-04-1031"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Maurizi</surname><given-names>MR</given-names></name></person-group><article-title>4-O-carboxymethyl ascochlorin causes er stress and induced autophagy in human hepatocellular carcinoma cells</article-title><source>J Biol Chem</source><volume>287</volume><fpage>15661</fpage><lpage>15671</lpage><year>2012</year></element-citation></ref>
<ref id="b20-ol-06-04-1031"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells</article-title><source>Med Oncol</source><volume>28</volume><fpage>105</fpage><lpage>111</lpage><year>2001</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ol-06-04-1031" position="float">
<label>Figure 1</label>
<caption>
<p>Effects of DDP, IR or 3-MA on the viability and apoptosis of NPC cells. (A) Cells were treated with 0&#x02013;600 &#x003BC;mol/l DDP or 0&#x02013;10 Gy of IR for 24, 36 or 48 h and viability was measured by MTT assay. (B) Cells were treated with 6 &#x003BC;mol/l DDP or 4 Gy IR for 24 h and cell death was detected by Annexin V-FITC/PI. (C) Cells were treated with 6 &#x003BC;mol/l DDP or 4 Gy IR for 6, 16 and 24 h. (D) Cells were treated with 0&#x02013;10 mmol/l of 3-MA for 24, 36 or 48 h and viability was measured by MTT assay (n&#x0003D;3). DDP, cisplatin; IR, ionizing radiation, 3-MA, 3-methyladenine; NPC, nasopharyngeal carcinoma; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide; FITC, fluorescein isothiocyanate; PI, propidium iodide; LC3, microtubule-associated protein 1 light chain 3.</p></caption>
<graphic xlink:href="OL-06-04-1031-g00.gif"/></fig>
<fig id="f2-ol-06-04-1031" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of 3-MA with DDP or IR on the viability, apoptosis and autophagy of cultured NPC cells. (A) Cells were treated with 1 mmol/l 3-MA combined with 6 &#x003BC;mol/l DDP or 4 Gy IR for 24, 36 or 48 h and viability was measured by MTT assay. <sup>&#x0002A;</sup>P&lt;0.05 vs. control group. (B) Cells were treated with (a) fresh culture medium, (b) 0.6 &#x003BC;mol/1 DDP or (e) 0.4 Gy IR, (c) 0.1 mmol/l 3-MA and (d) 0.6 &#x003BC;mol/l DDP or (f) 0.4 Gy IR combined with 0.1 mmol/l 3-MA for 5 days. Cells were treated with 6 &#x003BC;mol/l DDP or 4 Gy IR in the presence or absence of 1 mmol/l 3-MA for 24 h. (C) Cells were collected for staining with JC-1; (D) cells were collected for staining with DAPI; (E) cells were subjected to western blot analysis; and (F) cells were collected for staining with anti-beclin 1 antibody (n&#x0003D;3). DDP, cisplatin; IR, ionizing radiation, 3-MA, 3-methyladenine; NPC, nasopharyngeal carcinoma; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide; LC3, microtubule-associated protein 1 light chain 3.</p></caption>
<graphic xlink:href="OL-06-04-1031-g01.gif"/></fig>
<fig id="f3-ol-06-04-1031" position="float">
<label>Figure 3</label>
<caption>
<p>Effects of 3-MA with 2-DG or TM on the viability and apoptosis of cultured NPC cells. (A) Cells were treated with various concentrations (0&#x02013;20 mmol/l) of 2-DG or (0&#x02013;32 &#x003BC;mol/l) of TM for 24, 36 and 48 h and cell viability was measured by MTT assay. (B) Cells were treated with 1mmol/l 3-MA combined with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM for 24, 36 and 48 h and cell viability was measured by MTT assay. <sup>&#x0002A;</sup>P&lt;0.05 vs. control group. (C) Cells were treated with (a) fresh culture medium, (b) 0.5 mmol/l 2-DG or (e) 0.1 &#x003BC;mol/l TM, (c) 0.1 mmol/l 3-MA and (d) 0.5 mmol/l 2-DG or (f) 0.1 &#x003BC;mol/l TM combined with 0.1 mmol/l 3-MA for 5 days. (D) Cells were treated with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM in the presence or absence of 1 mmol/l 3-MA for 24 h. Cells were collected for staining with JC-1 (n&#x0003D;3). 3-MA, 3-methyladenine; 2-DG, 2-deoxy-D-glucose; TM, tunicamycin; NPC, nasopharyngeal carcinoma; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide.</p></caption>
<graphic xlink:href="OL-06-04-1031-g02.gif"/></fig>
<fig id="f4-ol-06-04-1031" position="float">
<label>Figure 4</label>
<caption>
<p>Effects of 3-MA with 2-DG or TM on the apoptosis and autophagy of NPC cells. (A) Cells were treated with 6 &#x003BC;mol/l DDP or 4 Gy IR in the presence or absence of 1 mmol/l 3-MA for 24 h. Cells were collected for staining with DAPI. (B) Cells were treated with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM in the presence or absence of 1 mmol/l 3-MA for 24 h. (C) Cells were treated with 5 mmol/l 2-DG or 1 &#x003BC;mol/l TM in the presence or absence of 1 mmol/l 3-MA for 24 h. Cells were collected for staining with anti-beclin 1 antibody (n&#x0003D;3). 3-MA, 3-methyladenine; 2-DG, 2-deoxy-D-glucose; TM, tunicamycin; NPC, nasopharyngeal carcinoma; DDP, cisplatin; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide.</p></caption>
<graphic xlink:href="OL-06-04-1031-g03.gif"/></fig></floats-group></article>
